Product Code: BT 2398
"The nucleic acid isolation and purification market is projected to grow at a CAGR of 8.9% during the forecast period (2020-2025)."
The global nucleic acid isolation and purification market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. The major factors driving the growth of the market include increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments is expected to hinder the growth of the market.
"The instruments segment will grow at the highest rate during the forecast period."
On the basis of product, the nucleic acid isolation and purification market is segmented into kits, reagents, and instruments. In 2019, kits were the largest product segment in the market. Growth in this market can be attributed to the continuous focus of key market players on developing and launching new and advanced kits. However, the instruments segment is expected to grow at the highest rate during the forecast period.
"By type, the plasmid DNA isolation and purification segment accounted for the largest share of the nucleic acid isolation and purification market in 2019."
On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. The plasmid DNA isolation segment accounted for the largest share of the nucleic acid isolation and purification market in 2019. The large share of this market segment can be attributed to the wide use of purified plasmid DNA in a variety of downstream applications, such as PCR, sequencing, expression of proteins, gene therapy, and transfection.
"The market in the Asia Pacific is projected to witness the highest growth rate during the forecast period (2020-2025)."
North America accounted for the largest share of the nucleic acid isolation and purification market in 2019. Significant R&D spending in biotechnology and pharmaceutical companies, the large size of the biotechnology industry, technological advancements, and government support in the region are the key factors driving the growth of the nucleic acid isolation and purification market in North America. On the other hand, the Asia Pacific is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the increasing number of genomic projects and increasing R&D investments by pharmaceutical & biotechnology companies in this region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type (Supply-side): Tier 1 (29%), Tier 2 (37%), and Tier 3 (34%)
- By Category (Demand-side): Pharmaceutical & Biotechnology Companies (38%), Hospitals & Diagnostic Centers (30%), and Academic & Government Research Institutes (22%), and Other End Users (10%)
- By Designation: C-level (37%), Director-level (23%), and Managers (40%)
- By Region: North America (37%), Europe (30%), Asia Pacific (21%), and the RoW (12%)
QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the leading players in the global nucleic acid isolation and purification market. Other notable players in this market include Promega Corporation (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Danaher Corporation (US), GE Healthcare (US), Illumina, Inc. (US), Merck KGaA (Germany), Takara Bio (Japan), Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada), Omega Bio-tek (US), Genaxxon Bioscience GmbH (Germany), 3B BlackBio Biotech India Limited (India), Invitek Molecular (Germany), BioVision (US), and Analytik Jena AG (Germany).
Research Coverage:
The report analyzes the nucleic acid isolation and purification market and aims at estimating the market size and future growth potential of this market based on various segments such as product, method, type, application, end user, and region. The report also includes the competitive analysis of the key players in this market, along with their company profiles, product & service offerings, recent developments, and key market strategies.
Reasons to Buy the Report:
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.
This report provides insights into the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the nucleic acid isolation and purification market. The report analyzes the market based on the product, type, application, end user, and region.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the nucleic acid isolation and purification market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of nucleic acid isolation and purification solutions across regions.
- Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the nucleic acid isolation and purification market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the nucleic acid isolation and purification market.
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 OBJECTIVES OF THE STUDY
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
- 1.3 MARKET SCOPE
- 1.3.1 MARKETS COVERED
- 1.3.2 YEARS CONSIDERED FOR THE STUDY
- 1.4 CURRENCY
- 1.5 LIMITATIONS
- 1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
- 2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
- 2.1.1.1 Key data from secondary sources
- 2.1.2 PRIMARY DATA
- 2.1.2.1 Key data from primary sources
- 2.1.2.2 Breakdown of primary sources
- 2.2 MARKET SIZE ESTIMATION
- 2.3 MARKET GROWTH RATE PROJECTIONS
- 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5 MARKET SHARE ESTIMATION
- 2.6 ASSUMPTIONS FOR THE STUDY
- 2.7 LIMITATIONS FOR RESEARCH
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
- 4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
- 4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT (2019)
- 4.3 GEOGRAPHICAL SNAPSHOT OF THE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
5 MARKET OVERVIEW
- 5.1 MARKET DYNAMICS
- 5.1.1 DRIVERS
- 5.1.1.1 Increasing R&D activities
- 5.1.1.2 Technological advancements and increasing automation
- 5.1.2 RESTRAINTS
- 5.1.2.1 High cost of automated instruments
- 5.1.3 OPPORTUNITIES
- 5.1.3.1 High scope of growth in emerging economies
- 5.1.3.2 Improving regulatory and reimbursement scenario
- 5.1.3.3 Molecular diagnostics and personalized medicine
- 5.1.4 TRENDS
- 5.1.4.1 Impact of the COVID-19 pandemic
- 5.1.4.2 Increase in government funding
6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT
- 6.1 INTRODUCTION
- 6.2 KITS
- 6.2.1 KITS WERE THE LARGEST PRODUCT SEGMENT IN THE MARKET IN 2019
- 6.3 REAGENTS
- 6.3.1 REAGENTS SEGMENT TO GROW AT A STEADY RATE DURING THE FORECAST PERIOD
- 6.4 INSTRUMENTS
- 6.4.1 AUTOMATED INSTRUMENTS ENABLE A FASTER, CLEANER, AND MORE CONSISTENT NUCLEIC ACID EXTRACTION PROCESS
7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD
- 7.1 INTRODUCTION
- 7.2 COLUMN-BASED ISOLATION AND PURIFICATION
- 7.2.1 COLUMN-BASED ISOLATION AND PURIFICATION WAS THE LARGEST SEGMENT IN THE MARKET IN 2019
- 7.3 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
- 7.3.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
- 7.4 REAGENT-BASED ISOLATION AND PURIFICATION
- 7.4.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
- 7.5 OTHER ISOLATION AND PURIFICATION METHODS
8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE
- 8.1 INTRODUCTION
- 8.2 PLASMID DNA ISOLATION AND PURIFICATION
- 8.2.1 PLASMID DNA ISOLATION AND PURIFICATION ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET
- 8.3 TOTAL RNA ISOLATION AND PURIFICATION
- 8.3.1 TOTAL RNA ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH
- 8.4 GENOMIC DNA ISOLATION AND PURIFICATION
- 8.4.1 GENOMIC DNA ISOLATION IS THE FIRST STEP IN GENETIC-BASED TESTS
- 8.5 MESSENGER RNA ISOLATION AND PURIFICATION
- 8.5.1 MESSENGER RNA ISOLATION AND PURIFICATION IS MAINLY USED IN THE STUDY OF GENE EXPRESSION AND TRANSCRIPTOMICS
- 8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
- 8.6.1 CLINICAL APPLICATIONS TO DRIVE THE MARKET FOR CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
- 8.7 MICRORNA ISOLATION AND PURIFICATION
- 8.7.1 MICRORNA KITS PROVIDE RAPID ISOLATION AND PURIFICATION OF RNA MOLECULES FROM SAMPLES
- 8.8 PCR CLEANUP
- 8.8.1 TIME-CONSUMING LABORATORY PROCEDURES TO LIMIT THE GROWTH OF THIS MARKET DURING THE FORECAST PERIOD
- 8.9 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION
- 9.1 INTRODUCTION
- 9.2 DIAGNOSTICS
- 9.2.1 DIAGNOSTIC APPLICATIONS FORM THE LARGEST AND FASTEST-GROWING SEGMENT IN THE MARKET
- 9.3 DRUG DISCOVERY & DEVELOPMENT
- 9.3.1 NGS BENEFITS DRUG DISCOVERY APPLICATIONS IN VARIOUS THERAPEUTIC AREAS
- 9.4 PERSONALIZED MEDICINE
- 9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE THE MARKET FOR THIS SEGMENT
- 9.5 AGRICULTURE & ANIMAL RESEARCH
- 9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
- 9.6 OTHER APPLICATIONS
10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 HOSPITALS & DIAGNOSTIC CENTERS
- 10.2.1 AVAILABILITY OF GENETIC TESTS AND RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
- 10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
- 10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE THE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
- 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS IS EXPECTED TO DRIVE THE MARKET
- 10.5 CONTRACT RESEARCH ORGANIZATIONS
- 10.5.1 CONTRACT RESEARCH ORGANIZATIONS ARE EXPECTED TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD
- 10.6 OTHER END USERS
11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.1.1 Government and private funding to support market growth in the US
- 11.2.2 CANADA
- 11.2.2.1 Demand for nucleic acid isolation and purification in Canada is increasing primarily due to growing investments in genomics
- 11.3 EUROPE
- 11.3.1 GERMANY
- 11.3.1.1 Germany is the largest market for nucleic acid isolation and purification in Europe
- 11.3.2 UK
- 11.3.2.1 Government support for research in the form of investments, funds, and grants to support market growth
- 11.3.3 FRANCE
- 11.3.3.1 High cancer burden in France to drive market growth
- 11.3.4 ROE
- 11.4 ASIA PACIFIC
- 11.4.1 CHINA
- 11.4.1.1 China to register the highest growth in the nucleic acid isolation and purification market in APAC
- 11.4.2 JAPAN
- 11.4.2.1 Japan to register steady growth during the forecast period
- 11.4.3 INDIA
- 11.4.3.1 Strong growth trends in the pharmaceutical & biotechnology industries to drive the market in India
- 11.4.4 ROAPAC
- 11.5 REST OF THE WORLD
- 11.5.1 LATIN AMERICA
- 11.5.1.1 To prevent cancer mortality, the Brazilian government recommends screening programs for breast and prostate cancer
- 11.5.2 MIDDLE EAST & AFRICA
- 11.5.2.1 Lack of infrastructure for research to hamper the growth of the NAIP market in the Middle East & Africa
12 COMPETITIVE LANDSCAPE
- 12.1 INTRODUCTION
- 12.2 MARKET EVALUATION FRAMEWORK
- 12.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS
- 12.4 COMPETITIVE SCENARIO
- 12.4.1 COLLABORATIONS & AGREEMENTS
- 12.4.2 PRODUCT LAUNCHES & APPROVALS
- 12.4.3 ACQUISITIONS
- 12.4.4 EXPANSIONS
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES
- 13.1 COMPANY EVALUATION MATRIX
- 13.1.1 MARKET SHARE ANALYSIS
- 13.2 COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
- 13.2.1 STARS
- 13.2.2 EMERGING LEADERS
- 13.2.3 PERVASIVE PLAYERS
- 13.2.4 EMERGING COMPANIES
14 COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*
- 14.1 QIAGEN N.V.
- 14.2 THERMO FISHER SCIENTIFIC
- 14.3 F. HOFFMAN-LA ROCHE AG
- 14.4 PROMEGA CORPORATION
- 14.5 AGILENT TECHNOLOGIES
- 14.6 BIO-RAD LABORATORIES
- 14.7 DANAHER CORPORATION
- 14.8 GE HEALTHCARE
- 14.9 ILLUMINA
- 14.10 MERCK KGAA
- 14.11 TAKARA BIO, INC.
- 14.12 NEW ENGLAND BIOLABS
- 14.13 ZYMO RESEARCH
- 14.14 NORGEN BIOTEK
- 14.15 OMEGA BIO-TEK, INC.
- 14.16 OTHER COMPANIES
- 14.16.1 GENAXXON BIOSCIENCE GMBH
- 14.16.2 3B BLACKBIO BIOTECH INDIA LTD.
- 14.16.3 INVITEK MOLECULAR GMBH
- 14.16.4 BIOVISION
- 14.16.5 ANALYTIK JENA AG
Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 AVAILABLE CUSTOMIZATIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS